Improving the Impact of CNS Field-Based Medical Teams in Major Global Markets: Optimizing Staffing & Resources

Consequently, organizations looking to expand their CNS footprint in high-potential global markets must prepare field-based medical teams to effectively engage thought leaders and payers.

Best Practices, LLC conducted this benchmarking research to help companies fill knowledge gaps around key CNS MSL/field-based medical team operational areas, including: staffing levels, resource allocations, and preferred MSL qualification and experience. This research also will help identify key deficiencies and opportunities for overcoming challenges, such as integrating HOLs into the field team, covering large key accounts, and measuring overall MSL value and effectiveness.

This research provides data in several segments: All Participants (Total Benchmark Class); Global (Outside US); North America Responses; and Europe Responses.

KEY TOPICS

• Optimization of CNS field-based medical team staffing levels
• Regional differences when building CNS field-based medical teams
• Number of thought leaders that are supported by MSLs
• How CNS field teams are staffed depending on stage of product lifecycle
• Budget allocations and revenue supported per MSL

• On average, how many total products (including both in-line and in development products) does an MSL support within the primary country?
• How many total field based medical staff are allocated to each of the listed roles?
• What percentage of thought leaders served by an individual MSL are KOLs versus HCPs?
• How many large key accounts does each of your MSL support on average?
• On average, how many payers does each of your HOL support?
• On average, what percentage of the peak MSL team size is assigned to support a product at each phase of the typical product lifecycle?
• How effective is it to bring an MSL onboard to support a product in each phase of the product lifecycle?
• On average, how many years of MSL experience do your MSLs have?
• What is the average approximate revenue supported by each MSL (in-line revenue only)?

• Effective MSL Backgrounds:
  • More than 40% of MSLs are pharmacists, with ~35% being scientists or physicians.
  • MSLs are most likely to have a pharmacist background (43%). MSLs with backgrounds as a scientist (38%) or physician (32%) are also common. Just 9% of MSLs are former nurses. U.S. field-medical teams make extensive use of pharmacists (54% of all MSLs), while EU5 field teams leverage scientists and physicians more heavily (nearly 60%).

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.